|
University of California, Irvine School of Medicine |
Second Annual Clinical Psychopharmacology Conference |
20 |
Yes |
9/28/2024 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Second Stage Labor-Part I: Risk Exposure Case Study |
0.5 |
Yes |
10/14/2024 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Second Stage Labor-Part II: Management & Risk Mitigation |
0.5 |
Yes |
10/14/2024 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Second Stage of Labor Management |
1 |
Yes |
5/12/2024 |
|
JAMA |
Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households |
1 |
Yes |
3/7/2025 |
|
JAMA Network Open |
Secondary Use of COVID-19 Symptom Incidence Among Hospital Employees as an Example of Syndromic Surveillance of Hospital Admissions Within 7 Days |
1 |
Yes |
6/21/2024 |
|
JAMA |
Sedentary Behavior and Incident Dementia Among Older Adults |
1 |
Yes |
9/12/2026 |
|
American Medical Association |
Self-Measured Blood Pressure Essentials: Student Edition |
0.5 |
Yes |
5/2/2026 |
|
JAMA Network Open |
Self-reported Illness Experiences and Psychosocial Outcomes for Reservation-Area American Indian Youth During COVID-19 |
1 |
Yes |
9/19/2025 |
|
JAMA Network Open |
Self-reported Memory Problems 8 Months After COVID-19 Infection |
1 |
Yes |
8/4/2024 |
|
JAMA Network Open |
Self-reported Mental and Physical Health Among Norwegian Adolescents Before and During the COVID-19 Pandemic |
1 |
Yes |
8/30/2024 |
|
JAMA Network Open |
Self-reported vs Directly Observed Face Mask Use in Kenya |
1 |
Yes |
8/4/2024 |
|
JAMA Neurology |
Selfie-Induced Diagnostic Challenge in Horner Syndrome |
1 |
Yes |
10/30/2024 |
|
JAMA Network Open |
Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital |
1 |
Yes |
10/26/2025 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Sepsis: Early Recognition and Treatment |
0.75 |
Yes |
8/11/2024 |
|
JAMA Oncology |
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer |
1 |
Yes |
8/4/2024 |
|
JAMA Oncology |
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer |
1 |
Yes |
8/4/2024 |
|
JAMA Network Open |
Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers |
1 |
Yes |
8/4/2024 |
|
JAMA |
Serologic Testing for Hepatitis B |
1 |
Yes |
11/19/2024 |
|
JAMA Internal Medicine |
Seronegative Chronic Hepatitis C Virus Infection - A Teachable Moment |
1 |
Yes |
11/1/2024 |
